AAIC 2025 Abstract

Evaluating blood‐based biomarkers for Alzheimer's disease diagnosis across ethnic groups: a systematic review

Abstract

Background: Alzheimer's disease (AD) manifests differently across racial and ethnic groups, influenced by genetic and environmental factors. Blood‐based biomarker testing has the potential to enable early detection of AD, facilitating timely intervention and effective management.

The paper

Queen Mary University of London; UCL Queen Square Institute of Neurology

AAIC 2025 Abstract, 24 Dec 2025, CC BY

Presented at AAIC 2025

doi.org/10.1002/alz70856_097986